Maine, New Hampshire and Vermont are receiving a total of $9.6 million as part of a nationwide settlement between the drug company Johnson & Johnson and 37 states.
The $181 million nationwide settlement with Johnson and Johnson subsidiary Janssen Pharmaceuticals is believed to be the largest multi-state consumer protection settlement ever.
Maine’s share is $2.7 million. New Hampshire’s is about $2.8 million and Vermont’s is $4.1 million.
The states allege that Janssen improperly marketed the anti-psychotic drugs Risperdal, Risperdal Consta, Risperdal M-Tab and Invega.
The complaint alleges that Janssen engaged in unfair and deceptive practices when it marketed Risperdal for unapproved uses. It says Janssen rewarded doctors who prescribed and promoted Risperdal for unapproved uses with lucrative consulting agreements.
Janssen did not admit wrongdoing as part of the settlement, under which it agreed it would not promote the drugs for off-label uses or make misleading claims.
Send questions/comments to the editors.
Success. Please wait for the page to reload. If the page does not reload within 5 seconds, please refresh the page.
Enter your email and password to access comments.
Hi, to comment on stories you must . This profile is in addition to your subscription and website login.
Already have a commenting profile? .
Invalid username/password.
Please check your email to confirm and complete your registration.
Only subscribers are eligible to post comments. Please subscribe or login first for digital access. Here’s why.
Use the form below to reset your password. When you've submitted your account email, we will send an email with a reset code.